Mohuczy D - Search Results

1

RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide.

Moreb JS, Mohuczy D, Ostmark B, Zucali JR. Moreb JS, et al. Among authors: mohuczy d. Cancer Chemother Pharmacol. 2007 Jan;59(1):127-36. doi: 10.1007/s00280-006-0233-6. Epub 2006 Apr 14. Cancer Chemother Pharmacol. 2007. PMID: 16614850

2

Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde.

Moreb JS, Gabr A, Vartikar GR, Gowda S, Zucali JR, Mohuczy D. Moreb JS, et al. Among authors: mohuczy d. J Pharmacol Exp Ther. 2005 Jan;312(1):339-45. doi: 10.1124/jpet.104.072496. Epub 2004 Oct 6. J Pharmacol Exp Ther. 2005. PMID: 15470086

3

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

Aquilante CL, Langaee TY, Lopez LM, Yarandi HN, Tromberg JS, Mohuczy D, Gaston KL, Waddell CD, Chirico MJ, Johnson JA. Aquilante CL, et al. Among authors: mohuczy d. Clin Pharmacol Ther. 2006 Apr;79(4):291-302. doi: 10.1016/j.clpt.2005.11.011. Epub 2006 Feb 28. Clin Pharmacol Ther. 2006. PMID: 16580898 Clinical Trial.

4

Presenilins in the heart: presenilin-2 expression is increased by low glucose and by hypoxia in cardiac cells.

Mohuczy D, Qian K, Phillips MI. Mohuczy D, et al. Regul Pept. 2002 Dec 31;110(1):1-7. doi: 10.1016/s0167-0115(02)00225-2. Regul Pept. 2002. PMID: 12468103

5

Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension.

Tang X, Mohuczy D, Zhang YC, Kimura B, Galli SM, Phillips MI. Tang X, et al. Among authors: mohuczy d. Am J Physiol. 1999 Dec;277(6):H2392-9. doi: 10.1152/ajpheart.1999.277.6.H2392. Am J Physiol. 1999. PMID: 10600860

6

Antisense inhibition of the Renin-Angiotensin system.

Mohuczy D, Ian Phillips M. Mohuczy D, et al. Methods Mol Med. 2001;51:83-104. doi: 10.1385/1-59259-087-X:83. Methods Mol Med. 2001. PMID: 21331711

7

Designing antisense to inhibit the renin-angiotensin system.

Mohuczy D, Phillips MI. Mohuczy D, et al. Mol Cell Biochem. 2000 Sep;212(1-2):145-53. Mol Cell Biochem. 2000. PMID: 11108146 Review.

8

Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits.

Yang BC, Phillips MI, Mohuczy D, Meng H, Shen L, Mehta P, Mehta JL. Yang BC, et al. Among authors: mohuczy d. Arterioscler Thromb Vasc Biol. 1998 Sep;18(9):1433-9. doi: 10.1161/01.atv.18.9.1433. Arterioscler Thromb Vasc Biol. 1998. PMID: 9743232

9

Antisense inhibition of AT1 receptor in vascular smooth muscle cells using adeno-associated virus-based vector.

Mohuczy D, Gelband CH, Phillips MI. Mohuczy D, et al. Hypertension. 1999 Jan;33(1 Pt 2):354-9. doi: 10.1161/01.hyp.33.1.354. Hypertension. 1999. PMID: 9931129

10

Antisense inhibition of the renin-angiotensin system in brain and peripheral organs.

Mohuczy D, Phillips MI. Mohuczy D, et al. Methods. 2000 Nov;22(3):197-209. doi: 10.1006/meth.2000.1071. Methods. 2000. PMID: 11071815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results